ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel

被引：0
|
作者：
Lifeng Wang
Jia Wei
Xiaoping Qian
Haitao Yin
Yang Zhao
Lixia Yu
Tingting Wang
Baorui Liu
机构：
[1] Drum Tower Hospital Affiliated to Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University,Department of Oncology
[2] Nanjing Medical University,Department of Epidemiology and Biostatistics, Epidemiology and Biostatistics Graduate Program, Data Analysis Center, School of Public Health
来源：
BMC Cancer | / 8卷
关键词：
Docetaxel; Gastric Cancer Patient; Nucleotide Excision Repair; Malignant Pleural Effusion; BRCA1 Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
    Wang, Lifeng
    Wei, Jia
    Qian, Xiaoping
    Yin, Haitao
    Zhao, Yang
    Yu, Lixia
    Wang, Tingting
    Liu, Baorui
    BMC CANCER, 2008, 8 (1)
  • [2] BRCA1 and β-tubulin III mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to docetaxel
    Liu, Baorui
    Wang, Lifeng
    Yin, Haitao
    Qian, Xiaoping
    Jia Wei
    Yu, Lixia
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (05) : 321 - 321
  • [3] BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer
    Lu Yuanming
    Zhang Lineng
    Song Baorong
    Peng Junjie
    Cai Sanjun
    BMC CANCER, 2013, 13
  • [4] The mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity of cisplatin, carboplatin and gemcitabine in human lung cancer cell lines
    Horio, Yoshitsugu
    Shimizu, Jun-ichi
    Osada, Hirotaka
    Hida, Toyoaki
    Hasegawa, Yoshinori
    Shimokata, Kaoru
    Takahashi, Takashi
    Sekido, Yoshitaka
    Yatabe, Yasushi
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3570S - 3571S
  • [5] mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines
    Shimizu, Junichi
    Horio, Yoshitsugu
    Osada, Hirotaka
    Hida, Toyoaki
    Hasegawa, Yoshinori
    Shimokata, Kaoru
    Takahashi, Takashi
    Sekido, Yoshitaka
    Yatabe, Yasushi
    RESPIROLOGY, 2008, 13 (04) : 510 - 517
  • [6] XPG mRNA Expression Levels Modulate Prognosis in Resected Non-Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression
    Bartolucci, Roberta
    Wei, Jia
    Sanchez, Jose Javier
    Perez-Roca, Laia
    Chaib, Imane
    Puma, Francesco
    Farabi, Raffaele
    Mendez, Pedro
    Roila, Fausto
    Okamoto, Tatsuro
    Taron, Miquel
    Rosell, Rafael
    CLINICAL LUNG CANCER, 2009, 10 (01) : 47 - 52
  • [7] ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin
    Tiseo, M.
    Bordi, P.
    Bortesi, B.
    Boni, L.
    Boni, C.
    Baldini, E.
    Grossi, F.
    Recchia, F.
    Zanelli, F.
    Fontanini, G.
    Naldi, N.
    Campanini, N.
    Azzoni, C.
    Bordi, C.
    Ardizzoni, A.
    BRITISH JOURNAL OF CANCER, 2013, 108 (08) : 1695 - 1703
  • [8] ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin
    M Tiseo
    P Bordi
    B Bortesi
    L Boni
    C Boni
    E Baldini
    F Grossi
    F Recchia
    F Zanelli
    G Fontanini
    N Naldi
    N Campanini
    C Azzoni
    C Bordi
    A Ardizzoni
    British Journal of Cancer, 2013, 108 : 1695 - 1703
  • [9] ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer
    Chunxia Su
    Songwen Zhou
    Ling Zhang
    Shengxiang Ren
    Jianfang Xu
    Jie Zhang
    Meijun Lv
    Jie Zhang
    Caicun Zhou
    Medical Oncology, 2011, 28 : 1411 - 1417
  • [10] ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer
    Su, Chunxia
    Zhou, Songwen
    Zhang, Ling
    Ren, Shengxiang
    Xu, Jianfang
    Zhang, Jie
    Lv, Meijun
    Zhang, Jie
    Zhou, Caicun
    MEDICAL ONCOLOGY, 2011, 28 (04) : 1411 - 1417
12345